M&A Deal Summary

restor3d Acquires Conformis

On June 22, 2023, restor3d acquired medical products company Conformis

Acquisition Highlights
  • This is restor3d’s 1st transaction in the Medical Products sector.
  • This is restor3d’s 1st transaction in the United States.
  • This is restor3d’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2023-06-22
Target Conformis
Sector Medical Products
Buyer(s) restor3d
Deal Type Add-on Acquisition
Advisor(s) UBS Investment Bank (Financial)
Hogan Lovells (Legal)

Target

Conformis

Billerica, Massachusetts, United States
Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. The company's product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant Platinum Services Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis is based in Billerica, Massachusetts.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

restor3d

Durham, North Carolina, United States

Category Company
Sector Medical Products
DESCRIPTION

restor3d is a medical device company focused on enabling surgeons to improve the reconstruction and repair of the human body through 3D-printed orthopedic medical devices with enhanced anatomical fit and superior integrative properties. restor3d seeks to improve medical device solutions by leveraging expertise in 3D printing of osseointegrative biomedical materials, biomechanics modeling, and artificial intelligence-based planning and design automation tools. restor3d is based in Durham, North Carolina.


DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1